Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Receives $20.71 Consensus Price Target from Brokerages

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has received a consensus rating of “Moderate Buy” from the nine research firms that are presently covering the company, Marketbeat reports. Five research analysts have rated the stock with a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $20.7143.

Several brokerages have recently issued reports on SBRA. Truist Financial upped their target price on shares of Sabra Healthcare REIT from $18.00 to $20.00 and gave the company a “hold” rating in a research report on Tuesday, September 2nd. Wells Fargo & Company increased their price objective on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 27th. Weiss Ratings reissued a “buy (b)” rating on shares of Sabra Healthcare REIT in a research report on Wednesday, October 8th. Cantor Fitzgerald started coverage on shares of Sabra Healthcare REIT in a research report on Wednesday, October 1st. They issued a “neutral” rating and a $20.00 price objective on the stock. Finally, BMO Capital Markets increased their price objective on shares of Sabra Healthcare REIT from $19.00 to $22.00 and gave the stock a “market perform” rating in a research report on Monday, August 25th.

Sabra Healthcare REIT Stock Up 1.1%

Shares of NASDAQ SBRA opened at $17.80 on Friday. The firm’s 50-day moving average price is $18.69 and its 200-day moving average price is $18.17. The company has a current ratio of 4.80, a quick ratio of 4.80 and a debt-to-equity ratio of 0.91. The stock has a market capitalization of $4.27 billion, a price-to-earnings ratio of 23.42, a P/E/G ratio of 1.18 and a beta of 0.85. Sabra Healthcare REIT has a 12-month low of $15.60 and a 12-month high of $20.03.

Sabra Healthcare REIT (NASDAQ:SBRA) last announced its earnings results on Monday, August 4th. The real estate investment trust reported $0.38 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.02. The firm had revenue of $189.15 million for the quarter, compared to analysts’ expectations of $185.64 million. Sabra Healthcare REIT had a net margin of 24.87% and a return on equity of 6.69%. The business’s revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.36 EPS. Sabra Healthcare REIT has set its FY 2025 guidance at 1.450-1.470 EPS. On average, equities research analysts anticipate that Sabra Healthcare REIT will post 1.45 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, August 29th. Investors of record on Friday, August 15th were given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.7%. The ex-dividend date of this dividend was Friday, August 15th. Sabra Healthcare REIT’s dividend payout ratio is 157.89%.

Institutional Trading of Sabra Healthcare REIT

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC bought a new position in Sabra Healthcare REIT in the 1st quarter worth about $298,000. New York State Teachers Retirement System grew its stake in Sabra Healthcare REIT by 12.1% in the 1st quarter. New York State Teachers Retirement System now owns 321,647 shares of the real estate investment trust’s stock worth $5,619,000 after acquiring an additional 34,591 shares in the last quarter. M&T Bank Corp grew its stake in Sabra Healthcare REIT by 2.1% in the 1st quarter. M&T Bank Corp now owns 51,827 shares of the real estate investment trust’s stock worth $905,000 after acquiring an additional 1,059 shares in the last quarter. Cambridge Investment Research Advisors Inc. grew its stake in Sabra Healthcare REIT by 4.7% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 18,921 shares of the real estate investment trust’s stock worth $331,000 after acquiring an additional 853 shares in the last quarter. Finally, Ethos Financial Group LLC bought a new position in Sabra Healthcare REIT in the 1st quarter worth about $1,150,000. 99.40% of the stock is owned by hedge funds and other institutional investors.

Sabra Healthcare REIT Company Profile

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.